VILLANO, GIANMARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.299
EU - Europa 330
AS - Asia 250
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.880
Nazione #
US - Stati Uniti d'America 2.298
CN - Cina 222
IT - Italia 107
FI - Finlandia 67
SE - Svezia 55
DE - Germania 45
GB - Regno Unito 22
IN - India 16
UA - Ucraina 15
IE - Irlanda 6
FR - Francia 5
HK - Hong Kong 5
BG - Bulgaria 3
KR - Corea 2
TH - Thailandia 2
BD - Bangladesh 1
CA - Canada 1
EU - Europa 1
HU - Ungheria 1
JP - Giappone 1
NL - Olanda 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 2.880
Città #
Fairfield 325
Chandler 252
Woodbridge 218
Ann Arbor 189
Wilmington 149
Ashburn 145
Houston 144
Jacksonville 125
Seattle 118
Cambridge 109
Padova 56
Princeton 42
Des Moines 40
Medford 40
Beijing 37
Roxbury 37
Helsinki 32
San Diego 32
Guangzhou 27
Nanjing 26
Dearborn 25
Boardman 23
Changsha 13
Hebei 13
Nanchang 13
Pune 13
Kunming 10
Shenyang 10
Hefei 9
Jinan 9
Jiaxing 7
London 7
Cagliari 6
Dublin 6
Norwalk 5
Falls Church 4
Paris 4
Pesaro 4
Shanghai 4
Wuhan 4
Zhengzhou 4
Baotou 3
Haikou 3
Kharkiv 3
Ningbo 3
Phoenix 3
Rockville 3
Sofia 3
Tianjin 3
Bangkok 2
Benevento 2
Campodarsego 2
Columbus 2
Florence 2
Gubbio 2
Hangzhou 2
Hong Kong 2
Hounslow 2
Incheon 2
Kilburn 2
Kirkland 2
Milan 2
New York 2
Novara 2
Redmond 2
Rome 2
Urbino 2
Araihazar 1
Arezzo 1
Belgrade 1
Bellevue 1
Bergamo 1
Borås 1
Budapest 1
Cascina 1
Central 1
Chicago 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Genoa 1
Harbin 1
Iligan City 1
Indiana 1
Lanzhou 1
Lappeenranta 1
Las Vegas 1
Munich 1
New Bedfont 1
Ogden 1
Portland 1
Porto 1
Southwark 1
Staten Island 1
Tappahannock 1
Tokyo 1
Viareggio 1
Washington 1
Zola Predosa 1
Totale 2.428
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 178
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 172
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 146
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 110
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 104
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 100
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 91
Hepatic progenitor cells express SerpinB3 91
Role of microglial activation via SERPINB3 in experimental acute hepatic encephalopathy 91
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 87
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 86
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 82
Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis 77
Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante 76
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 75
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 73
Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. 73
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 67
Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico 66
Caratterizzazione di un modello di topo transgenico per SERPINB3 umana 66
Serpin B3 differently up-regulates hypoxia inducible factors -1α and -2α in hepatocellula arcinoma: Mechanisms revealing novel potential therapeutic targets 61
SERPINB3 is associated with longer survival in transgenic mice. 61
Overexpression of SERPINB3 in hepatic progenitor cells in a mouse model of acute liver injury 59
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 57
Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model 55
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 53
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 51
RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA 50
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 46
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 45
SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis. 45
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 44
SERPINB3 è associata a una maggior sopravvivenza in un modello di topo transgenico. 43
SERPIN B3 TRANSGENIC MICE ARE MORE SUSCEPTIBLE TO LUNG FIBROSIS AND EPITHELIAL PROLIFERATION 39
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 38
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 38
HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY 29
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 29
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 28
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 22
SERPINB3 transgenic mice are more susceptible to lung fibrosis and epithelial proliferation 21
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 19
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 18
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 10
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 9
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 6
SerpinB3 as hepatic marker of post-resective shear stress 6
Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study 6
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 3
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 3
Totale 2.905
Categoria #
all - tutte 9.844
article - articoli 6.954
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 88
selected - selezionate 0
volume - volumi 0
Totale 16.886


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019186 0 0 0 0 0 0 0 0 0 37 65 84
2019/2020707 88 25 15 113 62 46 92 71 67 72 34 22
2020/2021388 22 19 13 15 4 20 11 19 58 126 56 25
2021/2022427 9 53 55 35 15 27 16 38 15 11 40 113
2022/2023540 84 46 22 53 90 84 1 50 80 2 23 5
2023/2024230 7 57 52 22 14 30 19 19 6 4 0 0
Totale 2.905